Abstract
To study rituximab in pediatric neuromyelitis optica (NMO)/NMO spectrum disorders (NMOSD) and the relationship between rituximab, B cell repopulation, and relapses in order to improve rituximab monitoring and redosing. Multicenter retrospective study of 16 children with NMO/NMOSD receiving ≥2 rituximab courses. According to CD19 counts, events during rituximab were categorized as "repopulation," "depletion," or "depletion failure" relapses (repopulation threshold CD19 ≥10 × 10(6) cells/L). The 16 patients (14 girls; mean age 9.6 years, range 1.8-15.3) had a mean of 6.1 events (range 1-11) during a mean follow-up of 6.1 years (range 1.6-13.6) and received a total of 76 rituximab courses (mean 4.7, range 2-9) in 42.6-year cohort treatment. Before rituximab, 62.5% had received azathioprine, mycophenolate mofetil, or cyclophosphamide. Mean time from rituximab to last documented B cell depletion and first repopulation was 4.5 and 6.8 months, respectively, with large interpatient variability. Earliest repopulations occurred with the lowest doses. Significant reduction between pre- and post-rituximab annualized relapse rate (ARR) was observed (p = 0.003). During rituximab, 6 patients were relapse-free, although 21 relapses occurred in...Continue Reading
References
Dec 14, 2004·Lancet·Vanda A LennonBrian G Weinshenker
May 24, 2006·Neurology·D M WingerchukB G Weinshenker
Aug 21, 2007·Lancet Neurology·Dean M WingerchukBrian G Weinshenker
May 30, 2008·Neurology·A McKeonS J Pittock
Sep 10, 2008·Archives of Neurology·Anu JacobBruce A C Cree
Oct 8, 2008·Pediatrics·Timothy E LotzeJill V Hunter
Oct 24, 2008·Brain : a Journal of Neurology·S JariusW Kristoferitsch
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Mixalis L Kosmidis, Marinos C Dalakas
Apr 13, 2011·Neurology·H L PellkoferT Kuempfel
May 14, 2011·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Ichiro NakashimaAmit Bar-Or
May 31, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Gurdesh S BediWilliam A Sheremata
Dec 8, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Ju-Hong MinKwang Ho Lee
Jan 21, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Benjamin M GreenbergElliot Frohman
Feb 15, 2012·Archives of Neurology·Ingo KleiterUNKNOWN Neuromyelitis Optica Study Group
Feb 23, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Su-Hyun KimHo Jin Kim
May 31, 2012·Journal of Clinical Immunology·Honghao WangXueqiang Hu
Aug 24, 2012·Neurology·Joanna KitleyAngela Vincent
Mar 26, 2013·Journal of the Neurological Sciences·Viktoria GredlerAndreas Lutterotti
Jul 31, 2013·JAMA Neurology·Su-Hyun KimHo Jin Kim
Nov 26, 2013·Journal of Neurology·Corinna TrebstUNKNOWN Neuromyelitis Optica Study Group (NEMOS)
Jan 1, 2014·Clinical Neurology and Neurosurgery·Christiane Wegner
Dec 21, 2013·PloS One·Sung-Min KimKwang-Woo Lee
Jan 22, 2014·JAMA Neurology·Maureen A MealyMichael Levy
Feb 11, 2014·Handbook of Clinical Neurology·Dean M Wingerchuk, Brian G Weinshenker
Apr 29, 2014·Pediatric Neurology·Shannon J BeresEmmanuelle Waubant
Jun 13, 2014·Neurology·Russell C DaleMing Lim
Aug 1, 2014·Pediatric Neurology·Dian HeLan Chu
Oct 24, 2014·Neurology. Neuroimmunology and Neuroinflammation·Russell C DaleFabienne Brilot
Dec 19, 2014·Neurology. Neuroimmunology and Neuroinflammation·Giulia LongoniE Ann Yeh
Citations
Jun 18, 2016·Current Treatment Options in Neurology·Marta Simone, Tanuja Chitnis
Sep 30, 2016·The International Journal of Neuroscience·Jie LinJunhui Xia
Feb 25, 2017·Current Opinion in Neurology·Russell C DaleMing Lim
Nov 17, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Sudarshini RamanathanUNKNOWN Australasian and New Zealand MOG Study Group
Jun 22, 2018·Nature Reviews. Neurology·Elizabeth WellsUNKNOWN attendees of the International Neuroimmune Meeting
Jun 5, 2019·Continuum : Lifelong Learning in Neurology·Tanuja Chitnis
Aug 31, 2019·Developmental Medicine and Child Neurology·Fahad AlbassamE Ann Yeh
May 1, 2018·Neurology. Neuroimmunology and Neuroinflammation·Erik EllwardtFrauke Zipp
Jan 11, 2017·Neurology·Michael J BradshawTanuja Chitnis
Aug 23, 2019·Current Opinion in Ophthalmology·Jane H LockJason H Peragallo
Jun 20, 2020·Multiple Sclerosis : Clinical and Laboratory Research·Angelo GhezziEmmanuelle Waubant
Aug 1, 2020·Neurology. Neuroimmunology and Neuroinflammation·Renata Barbosa PaoliloKumaran Deiva
Nov 16, 2016·Journal of Neurology·Andrea BianchiMario Mascalchi
Nov 9, 2018·Frontiers in Neurology·Nadja BorisowFriedemann Paul
Apr 18, 2019·Developmental Medicine and Child Neurology·Bahadir Konuskan, Banu Anlar
May 4, 2018·Current Treatment Options in Neurology·Grace Y Gombolay, Tanuja Chitnis
Jun 6, 2019·Children·Maria Milagros GalardiSoe Mar
Jul 2, 2019·Frontiers in Neurology·Frederike Cosima OertelFriedemann Paul
Feb 20, 2016·Neurology. Neuroimmunology and Neuroinflammation·Josep Dalmau
Oct 13, 2017·The EPMA Journal·Joseph KuchlingMichael Scheel
Jan 30, 2018·Expert Review of Molecular Diagnostics·Matteo GastaldiDiego Franciotta
Jun 12, 2020·Der Nervenarzt·Jonas GrafHans-Peter Hartung
Oct 5, 2020·Journal of Neurology·Trygve HolmøyØivind Torkildsen
Feb 2, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Jie LinJunhui Xia
Jan 24, 2021·Lancet Neurology·Giulia FaddaBrenda Banwell
Jul 17, 2020·Frontiers in Pediatrics·Silvia TenembaumUNKNOWN Guthy-Jackson Foundation International Clinical Consortium (GJCF-ICC)
Nov 13, 2020·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Arlette L BruijstensRinze F Neuteboom
May 2, 2021·The British Journal of Ophthalmology·Lindan XieShihui Wei
Jul 18, 2021·Current Problems in Pediatric and Adolescent Health Care·Ajay GoenkaGogi Kumar
Jul 24, 2021·Journal of Neuroimmunology·Elia SechiPaolo Solla